| Financial Year |
March 31 2023 |
| Monetary Funds |
309,845,793.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,543,564.38 |
| Accounts Receivable |
91,566,131.46 |
| Advances to Suppliers |
7,024,760.23 |
| Other Receivables |
17,099,042.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
144,474,065.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,401,410.10 |
| Total Current Assets |
610,473,511.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
18,920,256.51 |
| Fixed Assetes |
400,471,116.12 |
| Under-construction Projects |
1,576,124.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
35,757,994.54 |
| R&D expenses |
-- |
| Goodwill |
32,508,664.53 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,011,868.31 |
| Other Non-Current Assets |
2,774,481.76 |
| Sub-Total of Non-Current Assets |
493,969,042.13 |
| Total Assets |
1,104,442,553.60 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,091,040.55 |
| Accounts Payable |
46,238,383.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,769,481.30 |
| Taxes Payable |
21,692,491.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,844,308.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
729,820.92 |
| Other Current Liabilities |
134,741,686.14 |
| Sub-Total of Current Liabilities |
266,834,626.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
257,483.20 |
| Deferred Income Tax Liabilities |
4,334,049.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
25,585,556.23 |
| Total Liabilities |
292,420,182.25 |
| Paid-In Capital(Or Share Stock) |
577,209,600.00 |
| Capital Surplus |
-- |
| Surplus Reserve |
39,558,132.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
155,181,793.90 |
| Minority Stockholder's Interest |
40,072,845.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
771,949,526.04 |
| Owner's Equity（Stockholder's Equity） |
812,022,371.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,104,442,553.60 |
